![](/img/cover-not-exists.png)
Durable Responses Achieved in Patients with MYC-Altered Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated with Fimepinostat (CUDC-907): Combined Results from a Phase 1 and Phase 2 Study
Landsburg, Daniel, Ramchandren, Rod, Oki, Yasuhiro, Pagel, John, Lugtenburg, P.J., Gharavi, Robert, Ma, Anna, Tuck, David, Barta, Stefan K.Volume:
18
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2018.07.209
Date:
September, 2018
File:
PDF, 71 KB
english, 2018